Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1656
Gene Symbol: DDX6
DDX6
0.300 Biomarker group GENOMICS_ENGLAND Rare De Novo Missense Variants in RNA Helicase DDX6 Cause Intellectual Disability and Dysmorphic Features and Lead to P-Body Defects and RNA Dysregulation. 31422817 2019
Entrez Id: 22884
Gene Symbol: WDR37
WDR37
0.300 Biomarker group GENOMICS_ENGLAND De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia. 31327508 2019
Entrez Id: 23512
Gene Symbol: SUZ12
SUZ12
0.300 Biomarker group GENOMICS_ENGLAND PRC2-complex related dysfunction in overgrowth syndromes: A review of EZH2, EED, and SUZ12 and their syndromic phenotypes. 31724824 2019
Entrez Id: 54809
Gene Symbol: SAMD9
SAMD9
0.300 Biomarker group CTD_human SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7. 27182967 2016
Entrez Id: 10297
Gene Symbol: APC2
APC2
0.300 Biomarker group GENOMICS_ENGLAND Directional neuronal migration is impaired in mice lacking adenomatous polyposis coli 2. 22573669 2012
Entrez Id: 2245
Gene Symbol: FGD1
FGD1
0.300 Biomarker group CTD_human Two novel mutations confirm FGD1 is responsible for the Aarskog syndrome. 11093277 2000
Entrez Id: 2245
Gene Symbol: FGD1
FGD1
0.300 Biomarker group CTD_human A mutation in the pleckstrin homology (PH) domain of the FGD1 gene in an Italian family with faciogenital dysplasia (Aarskog-Scott syndrome). 10930571 2000
Entrez Id: 7042
Gene Symbol: TGFB2
TGFB2
0.300 Biomarker group CTD_human TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. 9217007 1997
Entrez Id: 2245
Gene Symbol: FGD1
FGD1
0.300 Biomarker group CTD_human Isolation and characterization of the faciogenital dysplasia (Aarskog-Scott syndrome) gene: a putative Rho/Rac guanine nucleotide exchange factor. 7954831 1994
Entrez Id: 815
Gene Symbol: CAMK2A
CAMK2A
0.100 CausalMutation group CLINVAR De Novo Mutations in Protein Kinase Genes CAMK2A and CAMK2B Cause Intellectual Disability. 29100089 2017
Entrez Id: 199713
Gene Symbol: NLRP7
NLRP7
0.100 Biomarker group HPO
Entrez Id: 2492
Gene Symbol: FSHR
FSHR
0.100 Biomarker group HPO
Entrez Id: 3655
Gene Symbol: ITGA6
ITGA6
0.100 Biomarker group HPO
Entrez Id: 10157
Gene Symbol: AASS
AASS
0.100 Biomarker group HPO
Entrez Id: 9968
Gene Symbol: MED12
MED12
0.100 Biomarker group HPO
Entrez Id: 7450
Gene Symbol: VWF
VWF
0.100 Biomarker group HPO
Entrez Id: 4763
Gene Symbol: NF1
NF1
0.100 CausalMutation group CLINVAR
Entrez Id: 5339
Gene Symbol: PLEC
PLEC
0.100 Biomarker group HPO
Entrez Id: 3691
Gene Symbol: ITGB4
ITGB4
0.100 Biomarker group HPO
Entrez Id: 7490
Gene Symbol: WT1
WT1
0.040 GeneticVariation group BEFREE The Wilms tumour (WT1) gene was first localized through its deletion in individuals with the WAGR syndrome (Wilms tumour, aniridia, genitourinary abnormalities and mental retardation). 7833922 1994
Entrez Id: 7490
Gene Symbol: WT1
WT1
0.040 Biomarker group BEFREE In several cases, children had genitourinary abnormalities of the type associated with the WT1 gene on chromosome 11p13. 7954323 1994
Entrez Id: 7490
Gene Symbol: WT1
WT1
0.040 GeneticVariation group BEFREE A point mutation found in the WT1 gene in a sporadic Wilms' tumor without genitourinary abnormalities is identical with the most frequent point mutation in Denys-Drash syndrome. 8381368 1993
Entrez Id: 7490
Gene Symbol: WT1
WT1
0.040 GeneticVariation group BEFREE All four del(11)(p13) cases presented with WAGR, a complex syndrome associated with a predisposition to Wilms' tumor (WT), aniridia (A), genitourinary abnormalities (G), and mental retardation (R). 2570677 1989
Entrez Id: 92579
Gene Symbol: G6PC3
G6PC3
0.020 Biomarker group BEFREE All patients had failure to thrive and some of the classic syndromic features of G6PC3 deficiency, including cardiac abnormalities and visibility of superficial veins in all, endocrinologic problems in PI and PIII, and urogenital abnormalities in PII. 26479985 2015
Entrez Id: 92579
Gene Symbol: G6PC3
G6PC3
0.020 Biomarker group BEFREE Glucose-6-phosphatase catalytic subunit 3 (G6PC3) deficiency is a newly described syndromic type of severe congenital neutropenia, associated with multiple organ abnormalities including facial, cardiac, and urogenital abnormalities, and increased visibility of superficial veins. 23018568 2013